Activation of AKT allows Bcl-2 to outcompete Bax, resulting in an anti-apoptotic response and upregulation of Bcl-2 has been shown to be an important mechanism of chemo-resistance in cancer cells (14, 15). This evidence concerns the gene BCL2 and cancer.